Thrombin Receptor Antagonists, Recent Advances in PAR-1 Antagonist Development

E-ISSN： 1875-533x|9|13|1229-1250

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.13, 2002-07, pp. : 1229-1250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents

By Chackalamannil Samuel Xia Yan

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 493-505

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 89-99

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances towards the discovery of ORL-1 receptor agonists and antagonists

By Bignan Gilles C Connolly Peter J Middleton Steven A

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 357-388

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in adenosine receptor antagonist research

By Hess Sonja

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. : 1533-1561

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in neurokinin-3 receptor antagonists

By Giardina G.A. Grugni M. Raveglia L.F.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 939-960

Informa Healthcare

Access to resources Recommend Favorite